Aurobindo Recalls Metformin Hydrochloride Tablets Due to Foreign Tablet Presence
Aurobindo Pharma is recalling Metformin Hydrochloride 1000 mg tablets because a foreign tablet was found in the bottle.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which indicates the product is not likely to cause adverse health consequences. The hazard involves a foreign tablet of the same active ingredient, which is a minor labeling/packaging error rather than a high-risk contamination.
Plain-English summary
Aurobindo Pharma Ltd. is recalling 7,476 bottles of Metformin Hydrochloride Tablets, USP 1000 mg, 500-count bottles. The recall is due to the presence of a foreign tablet, specifically Metformin BP 1000mg, found in a bottle of Metformin HCl 1000mg. The affected product is identified by Lot # MTSC17145-A with an expiration date of July 2021.
The product was distributed nationwide within the US. It is a prescription-only medication manufactured for Aurobindo Pharma USA, Inc. and manufactured by Aurobindo Pharma Limited in India.
Consumers should check their medication for the specific lot number and expiration date listed above. If the product matches the recall details, they should stop using it and contact their healthcare provider or pharmacist for further instructions.
The recalled product
- Product
- METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE)
- Brand
- METFORMIN HYDROCHLORIDE
- Manufacturer
- Aurobindo Pharma Ltd.
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 7,476
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot#: MTSC17145-A
- Exp. July 2021
UPCs (3)
- 0365862010018
- 0365862009012
- 0365862008015
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · METFORMIN HYDROCHLORIDE
- ModerateMetformin Hydrochloride Extended-Release Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2025-04-16
- HighMetformin Hydrochloride Extended-Release Tablets Recalled for Foreign Tablet Contamination
FDA (Drugs) · 2025-04-02
- SevereMetformin Hydrochloride Extended-Release Tablets Recalled for NDMA Contamination
FDA (Drugs) · 2022-02-02
- HighMetformin Hydrochloride Tablets Recalled for NDMA Contamination
FDA (Drugs) · 2021-06-30
- ModerateSun Pharmaceutical Recalls Metformin Hydrochloride Tablets Due to Foreign Substance
FDA (Drugs) · 2021-05-19
Same manufacturer · Aurobindo Pharma Ltd.
See all →- CriticalAurobindo Recalls Ampicillin and Sulbactam Injection Due to Glass Particulates
FDA (Drugs) · 2018-02-14
- SevereNorthstar Zolpidem Tartrate Tablets Recalled for Foreign Valacyclovir Contamination
FDA (Drugs) · 2012-11-14
Same hazard · foreign object
See all →- SevereOutshine Strawberry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Black Cherry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Grape Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Watermelon Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02